STEPHEN AKE

Allopathic & Osteopathic Physicians|Family Medicine FAIRBANKS, AK NPI 1659657948

General Payments — all program years on this page

$968.42

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 46
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $568.61 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $568.6121

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $70.456
2019 $15.771
2021 $29.992
2022 $18.261
2023 $265.3415
2024 $568.6121

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096719934 Novo Nordisk Inc $20.58 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104750454 AstraZeneca Pharmaceuticals LP $13.98 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114572033 Exact Sciences Corporation $16.80 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115413606 Amgen Inc. $19.96 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115971788 GlaxoSmithKline, LLC. $20.07 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118099930 Boehringer Ingelheim Pharmaceuticals, Inc. $18.57 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118099932 Boehringer Ingelheim Pharmaceuticals, Inc. $20.34 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118099934 Boehringer Ingelheim Pharmaceuticals, Inc. $22.08 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119421111 Medtronic, Inc. $27.29 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128745433 SANOFI PASTEUR INC. $15.11 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131848777 PFIZER INC. $26.66 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135403202 Lilly USA, LLC $15.07 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135431201 Lilly USA, LLC $16.48 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139356265 Astellas Pharma US Inc $21.62 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141584906 Merck Sharp & Dohme LLC $23.20 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146774726 IDORSIA PHARMACEUTICALS US INC $13.35 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148039156 Inspire Medical Systems, Inc. $53.74 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148039158 Inspire Medical Systems, Inc. $23.82 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150138241 SHIELD THERAPEUTICS INC $76.65 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150149568 SHIELD THERAPEUTICS INC $78.75 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153473031 Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.49 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.